Comparing WORK Medical Technology Group (NASDAQ:WOK) & TransMedics Group (NASDAQ:TMDX)

WORK Medical Technology Group (NASDAQ:WOK) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares WORK Medical Technology Group and TransMedics Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81 million	0.00	-$1.07 million	N/A	N/A
TransMedics Group	$605.49 million	6.20	$190.29 million	$4.90	22.32

TransMedics Group has higher revenue and earnings than WORK Medical Technology Group.

Institutional and Insider Ownership

99.7% of TransMedics Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

WORK Medical Technology Group has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations for WORK Medical Technology Group and TransMedics Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1	0	0	0	1.00
TransMedics Group	0	5	7	0	2.58

TransMedics Group has a consensus target price of $152.33, suggesting a potential upside of 39.30%. Given TransMedics Group’s stronger consensus rating and higher possible upside, analysts clearly believe TransMedics Group is more favorable than WORK Medical Technology Group.

Profitability

This table compares WORK Medical Technology Group and TransMedics Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
TransMedics Group	31.43%	30.17%	11.39%

Summary

TransMedics Group beats WORK Medical Technology Group on 11 of the 12 factors compared between the two stocks.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.